Oneness Biotech Co., Ltd. (TPEX:4743)

Oneness Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,048	812.83	5,655	332.96	217.64
Short-Term Investments	5,971	6,960	2,392	7,473	8,099
Cash & Short-Term Investments	7,019	7,773	8,047	7,806	8,317
Cash Growth	-9.70%	-3.40%	3.08%	-6.14%	423.69%
Accounts Receivable	18.34	25.77	13.08	14.59	444.45
Other Receivables	77.88	50.77	19.86	114.2	70.37
Receivables	96.22	76.54	32.95	128.79	514.82
Inventory	115.16	122.74	111.4	81.32	50.19
Other Current Assets	62.83	45.93	42.2	35.31	55.31
Total Current Assets	7,293	8,018	8,233	8,051	8,937
Property, Plant & Equipment	1,106	1,195	1,033	1,038	1,046
Long-Term Investments	3,737	4,096	3,920	3,871	2,585
Goodwill	57.44	89.14	89.14	89.14	89.14
Other Intangible Assets	1,125	1,682	2,010	2,388	2,474
Long-Term Accounts Receivable	-	-	-	32.41	32.94
Long-Term Deferred Tax Assets	137.57	79.21	97.46	62.85	38.67
Other Long-Term Assets	204.05	204.05	197.65	197.86	180.73
Total Assets	13,660	15,364	15,580	15,731	15,384
Accounts Payable	2.73	1.7	1.52	2.5	48.43
Accrued Expenses	103.57	119.05	155.39	78.16	58.6
Current Portion of Leases	41.18	34.25	13.25	12.73	23.23
Current Income Taxes Payable	0.12	0.12	12.69	35.1	-
Other Current Liabilities	35.32	60.24	25.76	28.75	23.44
Total Current Liabilities	182.92	215.36	208.6	157.24	153.69
Long-Term Leases	365.18	397.95	250.09	270.34	279.86
Long-Term Unearned Revenue	170.68	176.07	145.99	1,155	1,155
Long-Term Deferred Tax Liabilities	140.41	76.56	95.22	58.18	35.09
Other Long-Term Liabilities	0.47	0.48	0.48	0.48	0.48
Total Liabilities	859.65	866.43	700.38	1,642	1,625
Common Stock	4,791	4,545	3,910	3,853	3,771
Additional Paid-In Capital	7,623	9,050	8,637	9,469	9,157
Retained Earnings	-1,154	-1,267	359.98	-1,036	-633.57
Treasury Stock	-25.78	-25.78	-25.78	-47.38	-75.81
Comprehensive Income & Other	1,066	1,750	1,737	1,778	1,415
Total Common Equity	12,299	14,053	14,618	14,016	13,633
Minority Interest	501.02	444.07	262.28	72.95	126.38
Shareholders' Equity	12,800	14,497	14,880	14,089	13,760
Total Liabilities & Equity	13,660	15,364	15,580	15,731	15,384
Total Debt	406.35	432.2	263.34	283.07	303.09
Net Cash (Debt)	6,613	7,341	7,783	7,523	8,014
Net Cash Growth	-9.92%	-5.69%	3.46%	-6.13%	536.11%
Net Cash Per Share	13.83	15.50	16.50	16.52	18.80
Filing Date Shares Outstanding	478.03	476.23	466.02	458.4	447.43
Total Common Shares Outstanding	478.03	476.23	466.02	458.4	447.43
Working Capital	7,110	7,803	8,025	7,894	8,784
Book Value Per Share	25.73	29.51	31.37	30.58	30.47
Tangible Book Value	11,117	12,282	12,519	11,539	11,070
Tangible Book Value Per Share	23.26	25.79	26.86	25.17	24.74
Buildings	640.27	637.35	602.54	580.99	510.38
Machinery	554.04	547.55	522.99	456.01	399.52
Construction In Progress	1.98	18.24	-	13.03	48.15
Leasehold Improvements	58.15	27.56	14.56	14.01	9.16

Source: S&P Global Market Intelligence. Standard template. Financial Sources.